TELY — Telyrx Holdings Share Price
- CA$79.85m
- CA$78.34m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 55.05 | ||
| Price to Tang. Book | 55.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.19% | ||
| Return on Equity | -58.37% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
TelyRx Holdings Inc. is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform. Connecting patients with independent, state-licensed providers to access over 350 everyday medications across 48 states and territories in the United States, the Company fulfills prescriptions through licensed retail pharmacies in Florida and Texas, delivering medication directly. The Company's product categories include flu and infections, chronic conditions, digestive and travel, skin and hair, women's health, men's health, lifestyle, weight loss, doctor's notes, pets, and supplements. The Company's chronic conditions product categories include allergies, asthma, diabetes, dry eye, gingivitis, glaucoma, high cholesterol, and migraine. The Company's flu and infections product categories include anti-fungal, cold and flu, cold sores, ear and eye infections and herpes. Its doctor's notes product categories include excuse note and emotional support animal letter.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- April 2nd, 2025
- Public Since
- October 24th, 2025
- Sector
- Diversified Retail
- Industry
- Consumer Cyclicals
- Exchange
Toronto Stock Exchange
- Shares in Issue
- 26,353,729

- Address
- 365 Bay Street, Suite 800, Toronto, M5H 2V1
- Web
- Phone
- +1 4163613121
- Auditors
- MNP LLP
Similar to TELY
FAQ
As of Today at 23:39 UTC, shares in Telyrx Holdings are trading at CA$3.03. This share price information is delayed by 15 minutes.
Shares in Telyrx Holdings last closed at CA$3.03 and the price had moved by over the past 365 days. In terms of relative price strength the Telyrx Holdings share price has matched the Toronto Stock Exchange 300 Composite Index by over the past year.
There is no consensus recommendation for this security.
Find out moreTelyrx Holdings does not currently pay a dividend.
Telyrx Holdings does not currently pay a dividend.
Telyrx Holdings does not currently pay a dividend.
To buy shares in Telyrx Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$3.03, shares in Telyrx Holdings had a market capitalisation of CA$79.85m.
Here are the trading details for Telyrx Holdings:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: TELY
Based on an overall assessment of its quality, value and momentum Telyrx Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Telyrx Holdings. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -9.78%.
As of the last closing price of CA$3.03, shares in Telyrx Holdings were trading -4.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Telyrx Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$3.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Telyrx Holdings' directors





